stearoyl-CoA desaturase-1 inhibitors (Abbott Laboratories)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namestearoyl-CoA desaturase-1 inhibitors (Abbott Laboratories)
Drug Alias NameSCD-1 inhibitors (Abbott Laboratories)A-939572A-940856
ClassificationSmall molecules
Mechanisms of ActionAcyl-CoA desaturase inhibitors
TargetsAcyl-CoA desaturase
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott Laboratories
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A